The efficacy and safety of clomiphene citrate and metformin on ovulation induction in patients suffering from anovulatory infertility

Authors

  • Hardik Patel Department of Pharmacology, B. J. Medical College, Ahmedabad, Gujarat, India
  • Prakruti Patel Department of Pharmacology, B. J. Medical College, Ahmedabad, Gujarat, India
  • R. K. Dikshit Department of Pharmacology, B. J. Medical College, Ahmedabad, Gujarat, India
  • Samidh Shah Department of Pharmacology, B. J. Medical College, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20151366

Keywords:

Clomiphene citrate, Infertility, Metformin

Abstract

Background: Ovulation disorders are an important cause of infertility. Polycystic ovarian syndrome (PCOS) comprises almost 90% cases of all ovulatory disorders. Clomiphene citrate helps to stimulate ovulation. Recently, use of metformin to treat PCOS due to its insulin sensitizing property is increasing. Hence, this study was undertaken to evaluate efficacy and safety of clomiphene citrate and its combination with metformin on ovulation induction and pregnancy outcome in the treatment of anovulatory infertility.

Methods: This study was done in patients of primary infertility due to anovulatory cycles at Civil Hospital, Ahmedabad. Patients were treated with clomiphene citrate in incremental doses from 50 to 150 mg for a period of maximum 6 menstrual cycle. In patients of anovulatory infertility with PCOS, clomiphene citrate was given along with metformin. At every visit, abdominal and pelvic examination, the size of ovarian follicle, endometrial thickness by ultrasonography was recorded. Urine pregnancy test was done once the menstruation was overdue by 9 days. Adverse drug effects, if any were noted. If patient did not conceive, then whole treatment was repeated from the next menstrual cycle.

Results: Out of 53 patients, five patients were lost to follow-up. The mean age of the enrolled patients in the study was 26.04±7.78. There were 20 patients (41.67%) with body mass index (BMI) <25 kg/m2 while 28 patients (58.33%) with BMI above 25 kg/m2. Among 21 patients who received clomiphene citrate alone in the study, 12 patients were ovulated (57.12%). Among 27 patients (PCOS) who received clomiphene with metformin, 18 patients were ovulated (66.74%). Pregnancy rate was 23.8% with clomiphene citrate alone while in PCOS patients, the pregnancy rate was 25.91%. Both clomiphene citrate and metformin were well tolerated in most of the patients.

Conclusion: Ovulation rate was significantly higher compared to pregnancy rate. We could not find any benefit of adding metformin to the standard treatment with clomiphene citrate.

References

World Health Organization. Definition of Infertility and other Reproductive Disorders. Available at http://www.who.int/reproductivehealth/topics/infertility/definitions/en/. Accessed 09 October 2015.

Goossens V, Traeger-Synodinos J, Coonen E, De Rycke M, Moutou C, Pehlivan T, et al. ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009. Hum Reprod 2012;27(7):1887-911.

Women’s Health Council. Infertility Treatments for Women. A Review of the Bio-medical Evidence Full Report. Dublin: Women’s Health Council; 2009.

Cahill DJ, Wardle PG. Management of infertility. BMJ. 2002;325(7354):28-32.

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e1001356.

Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Hum Reprod. 2008;23(3):693-8.

Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6):551-66.

Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update. 2003;9(4):359-72.

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9.

Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006;332(7556):1485.

Dasari P, Pranahita G. The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS. J Hum Reprod Sci. 2009;2(1):18-22.

Homburg R. Clomiphene citrate – end of an era? A mini-review. Hum Reprod. 2005;20(8):2043-51.

Batukan C, Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2001;265(3):124-7.

Downloads

Published

2017-01-16

How to Cite

Patel, H., Patel, P., Dikshit, R. K., & Shah, S. (2017). The efficacy and safety of clomiphene citrate and metformin on ovulation induction in patients suffering from anovulatory infertility. International Journal of Basic & Clinical Pharmacology, 4(6), 1241–1246. https://doi.org/10.18203/2319-2003.ijbcp20151366

Issue

Section

Original Research Articles